Sarepta Therapeutics News

Express News | Sarepta Therapeutics Inc : JP Morgan Cuts Target Price to $175 From $177

Reuters00:38 ET

What Analysts Are Saying About Sarepta Therapeutics Stock

In the latest quarter, 14 analysts provided ratings for Sarepta Therapeutics (NASDAQ:SRPT), showcasing a mix of bullish and bearish perspectives.The table below provides a concise overview of recent r

Benzinga17:00 ET

Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says

Sarepta Therapeutics' (SRPT) regulatory review of its Elevidys therapy for Duchenne muscular dystrophy is advancing faster than anticipated, Morgan Stanley said in a report emailed Thursday. "Overall,

MT Newswires15:42 ET

Sarepta Elevidys Accelerated Approval Criticized by ICER Exec

Seeking Alpha15:36 ET

Sarepta Therapeutics Price Target Maintained With a $128.00/Share by Cantor Fitzgerald

Sarepta Therapeutics Price Target Maintained With a $128.00/Share by Cantor Fitzgerald

Dow Jones12:23 ET

Sarepta Therapeutics (NASDAQ:SRPT) Has Debt But No Earnings; Should You Worry?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh

Simply Wall StMay 2 10:37 ET

Express News | Sarepta Therapeutics Inc : UBS Raises Target Price to $173 From $167

ReutersMay 2 10:08 ET

Express News | Needham Reiterates Buy on Sarepta Therapeutics, Maintains $166 Price Target

BenzingaMay 2 06:51 ET

Sarepta Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 19.73% Needham → $166 Reiterates Buy → Buy 03/01/2024 20.45% UBS $164 → $167 Maintains Buy 02/2

BenzingaMay 2 06:50 ET

Buy Rating on Sarepta Therapeutics Amid Anticipated Label Expansion for Elevidys

TipRanksMay 2 06:45 ET

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Sarepta Therapeutics (SRPT) and Acadia Healthcare (ACHC)

TipRanksMay 2 06:23 ET

Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Sarepta Therapeutics (SRPT)

TipRanksMay 2 03:51 ET

Barclays Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT)

TipRanksMay 2 03:50 ET

Express News | Sarepta Therapeutics Inc : RBC Raises Target Price to $157 From $154

ReutersMay 2 03:04 ET

Apple, Kellanova And 3 Stocks To Watch Heading Into Thursday

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:Wall Street expects Apple Inc. (NASDAQ:AAPL) to report quarterly e

BenzingaMay 2 02:25 ET

Earnings Call Summary | Sarepta Therapeutics(SRPT.US) Q1 2024 Earnings Conference

The following is a summary of the Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript:Financial Performance:Sarepta reported Q1 net product revenue of $360 million, an increase of about

moomoo AIMay 2 01:39 ET · Conference Call

Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Yahoo FinanceMay 1 19:30 ET

Express News | Shares of Sarepta Therapeutics Rise 6% to $138.96 in Extended Trading Following Q1 Results

ReutersMay 1 18:40 ET

Express News | Sarepta Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results

BenzingaMay 1 16:55 ET

Express News | Sarepta Therapeutics Inc- Qtrly Elevidys Net Revenues for Quarter Totaled $133.9 Mln

ReutersMay 1 16:39 ET